Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
about
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guidelineIs physiological glucocorticoid replacement important in children?Management of Childhood Congenital Adrenal Hyperplasia-An Integrative Review of the Literature.Growth and reproductive outcomes in congenital adrenal hyperplasia.Blood Pressure and Left Ventricular Characteristics in Young Patients with Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyInfluence of the A3669G Glucocorticoid Receptor Gene Polymorphism on the Metabolic Profile of Pediatric Patients with Congenital Adrenal Hyperplasia.Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletesCardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Impact of glucocorticoid receptor gene polymorphisms on the metabolic profile of adult patients with the classical form of 21-hydroxylase deficiencyIncreased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyPubertal development among girls with classical congenital adrenal hyperplasia initiated on treatment at different agesMetabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Carotid Intima-Media Thickness Is Associated with Increased Androgens in Adolescents and Young Adults with Classical Congenital Adrenal HyperplasiaClassical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults.Clinical features of congenital adrenal insufficiency including growth patterns and significance of ACTH stimulation test.Late clinical presentation of congenital adrenal hyperplasia in older children: findings from national paediatric surveillance.An update to 21-hydroxylase deficient congenital adrenal hyperplasia.Two Siblings with the Same Severe Form of 21-Hydroxylase Deficiency But Different Growth and Menstrual Cycle Patterns.Management issues of congenital adrenal hyperplasia during the transition from pediatric to adult care.Clinical outcomes in the management of congenital adrenal hyperplasia.Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.The diagnosis and treatment of adrenal insufficiency during childhood and adolescence.Cardiovascular risk factors and increased carotid intima-media thickness in young patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency.Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.Left ventricular dysfunction and subclinical atherosclerosis in children with classic congenital adrenal hyperplasia: a single-center study from upper Egypt.Obesity in children with congenital adrenal hyperplasia in the Minnesota cohort: importance of adjusting body mass index for height-age.Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia24-hour blood pressure profiles in children with congenital adrenal hyperplasia on two different hydrocortisone treatment regimens.Adolescents with congenital adrenal hyperplasia because of 21-hydroxylase deficiency have vascular dysfunction.The challenge of delivering endocrine care and successful transition to adult services in adolescents with congenital adrenal hyperplasia: experience in a single centre over 18 years.Care provision in congenital adrenal hyperplasia - all doom and gloom or light at the end of the tunnel?Impact of nasal continuous positive airway pressure for congenital adrenal hyperplasia with obstructive sleep apnea and bruxism.Assessment of early atherosclerosis and left ventricular dysfunction in children with 21-hydroxylase deficiency.Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia.
P2860
Q24614223-C2246BCF-602B-4210-85C4-E0C71E100CDCQ28079724-B268877A-2C94-4F8A-B2DB-2E489D5EEB1DQ30148724-DB020002-90AF-41D0-B13D-9F56EE7D4C1DQ33635243-ABE5CFB5-569D-4C0B-998F-D77A91B7ED3EQ33651842-26C7AF15-B567-4995-B4FE-5C3A897A0BD0Q33890702-80EE9153-1E00-43B4-B65E-D4A39C9C489BQ34235764-356F243E-8AA8-4472-8976-9E9F52F40E7DQ34281138-5980EA16-9907-4245-9230-B6E30B2B2A49Q34377663-1BB5E267-9F18-418B-A2F8-18251BF36052Q34427620-63593014-333B-4B98-8C3D-83EA74E4C4C1Q35916502-C99AE462-8834-4542-96DF-B8A024A40872Q36107809-1FF066FA-088F-4FCB-BB1E-A0E761DE01C7Q36436509-C8FB533C-8525-446E-83B2-D794F99FE63CQ36442459-3C315D57-3090-492A-924C-88CED834E464Q36795530-3C76C287-04C9-408C-9636-9CB5D4F111FFQ36896732-DB4C61AA-8FE6-4B76-819D-A548522B8DBAQ37060194-B2340060-B2A0-43BA-AC25-2DC24606656DQ37329618-858A034B-4F09-42B3-A47E-3AA8ACDFAF66Q37465530-1B45AE5C-12FB-4768-AF55-7C01E7C8C7BAQ37508836-C6095050-3782-451E-AF25-41C5374BB1E5Q37672420-BDF5AC07-1986-4033-9FA9-42B50B807DA5Q37694354-EC6BD6AE-5582-4F56-8AE5-7C9DF64D7C4BQ37974156-E7CAADF1-44A9-4C2D-A45B-725B214A3828Q38529981-328013FD-89C5-4D21-BF2E-60C430F8C265Q38743172-8D71544A-F620-4803-A672-06307D81BA80Q38809480-E1BE3A3C-9293-48F1-98F1-95F6BB253051Q38931092-E12C0020-FD9A-484F-8D45-F3F4D4CD160FQ38948900-16049268-303C-4CB5-BD8C-5978EC7DBFE5Q39032544-F99EE5FB-6014-47BB-92D3-99E29F5E02DFQ39247750-9CBFE088-0F4A-4BB7-9A40-257A94F20092Q40335044-E1211BB6-1CFF-4692-AE6E-308F7D53CDC0Q40361756-91569616-7EC2-4501-8256-259F1816FCAEQ43289158-293F7614-55B1-477C-9881-94DE1EE0144CQ43715411-64A6F574-0940-4F6C-BD83-AB8B13E19D3FQ44045273-037BC50F-8437-4E73-A649-5BA925F0001CQ44914129-6FAE31F9-0932-4740-A31F-8DFBEB81DC78Q48316339-2B52ECA2-AAB4-4AF1-9C83-D1FE96726BE5Q51275699-D76594BC-5FB5-4E52-83DC-958000364B95Q51317526-318F1151-7EF2-42C3-9E65-84318297F46C
P2860
Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Obesity among children and ado ...... to 21-hydroxylase deficiency.
@en
Obesity among children and ado ...... to 21-hydroxylase deficiency.
@nl
type
label
Obesity among children and ado ...... to 21-hydroxylase deficiency.
@en
Obesity among children and ado ...... to 21-hydroxylase deficiency.
@nl
prefLabel
Obesity among children and ado ...... to 21-hydroxylase deficiency.
@en
Obesity among children and ado ...... to 21-hydroxylase deficiency.
@nl
P2093
P921
P356
P1433
P1476
Obesity among children and ado ...... to 21-hydroxylase deficiency.
@en
P2093
Christoph Beier
Diemud Simm
Helmuth G Dörr
Thomas M K Völkl
P304
P356
10.1542/PEDS.2005-1005
P407
P577
2006-01-01T00:00:00Z